Skip to main content

Table 2 Summary of outcomes for each agent

From: Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis

Type of intervention

Outcomes

TFG < 3

STR

LVEF

MACEs

AEs

Events

Total

Events

Total

Mean

SD

Total

Events

Total

Events

Total

Adenosine

82

978

538

931

48.80

11.72

502

115

959

258

796

Anisodamine

18

184

140

184

58.78

10.31

208

11

208

29

158

Diltiazem

20

88

43

88

54.21

12.33

88

12

88

19

54

Nicorandil

7

207

33

57

55.18

11.75

112

20

148

–

–

Nitroprusside

57

551

191

317

51.46

12.44

199

26

363

50

317

Urapidil

1

27

25

27

54.32

6.65

49

0

27

4

27

Verapamil

26

181

34

79

52.56

12.48

181

18

151

3

30

Control

263

1693

608

1219

50.57

10.88

943

228

1478

87

1008

  1. TFG, TIMI flow grade; STR, ST-segment resolution; LVEF, left ventricular ejection fraction; MACEs, major adverse cardiovascular events; AEs, adverse events
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us